Melanoma risk in association with serum leptin levels and lifestyle parameters: A case-control study

Annals of Oncology

Volumn 19, Issue 2, 2008, Pages 384-389

  Gogas, H ^a   Trakatelli, M ^b   Dessypris, N ^a   Terzidis, A ^a   Katsambas, A ^a   Chrousos, G P ^a   Petridou, E T ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alcohol; Diet; Exercise; Leptin; Melanoma

Indexed keywords

LEPTIN;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CANCER RISK; CARCINOGENESIS; CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FOOD INTAKE; FOOD PREFERENCE; GENETIC SUSCEPTIBILITY; HORMONE BLOOD LEVEL; HUMAN; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MELANOMA; OBESITY; PRIORITY JOURNAL; SMOKING; SOCIAL STATUS;

EID: 38849131932     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm464     Document Type: Article

References (51)

1. Boyle P, Maisonneuve P, Dore JF. Epidemiology of malignant melanoma. Br Med. Bull 1995; 51: 523-547.
2. De Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004; 40: 2355-2366.
3. Gandini S, Sera F, Catttaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma; I. Common and atypical naevi. Eur J Cancer 2005; 41: 28-44.
4. Gandini S, Sera F, Catttaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 45-60.
5. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 2040-2059.
6. Bain C, Green A, Siskind V et al. Diet and melanoma. An exploratory case-control study. Ann Epidemiol 1993; 3: 235-238.
7. Millen AE, Tucker MA, Hartge P et al. Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13: 1042-1051.
8. Naldi L, Gallus S, Tavani A et al. Risk of melanoma and vitamin A, coffee and alcohol: A case-control study from Italy. Eur J Cancer Prev 2004; 13: 503-508.
9. Le Marchand L, Saltzman BS, Hankin JH et al. Sun exposure, diet, and melanoma in Hawaii Caucasians. Am J Epidemiol 2006; 164: 232-245.
10. Kirkpatrick CS, White E, Lee JA. Case-control study of malignant melanoma in Washington state. II. Diet, alcohol, and obesity. Am J Epidemiol 1994; 139: 869-880.
11. Veierod MB, Thelle DS, Laake P. Diet and risk of cutaneous malignant melanoma: A prospective study of 50,757 Norwegian men and women. Int J Cancer 1997; 71: 600-604.
12. Feskanich D, Willett WC, Hunter DJ et al. Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women. Br J Cancer 2003; 88: 1381-1387.
13. Freedman DM, Sigurdson A, Doody MM et al. Risk of melanoma in relation to smoking, alcohol intake, and other factors in a large occupational cohort. Cancer Causes Control 2003; 14: 847-857.
14. Gallus S, Naldi L, Martin L et al. Anthropometrical measures and risk of cutaneous malignant melanoma: A case-control study from Italy. Melanoma Res 2006; 16: 83-87.
15. Thune I, Olsen A, Albrektsen G, Tretli S. Cutaneous malignant melanoma: association with height, weight and body-surface area. a prospective study in Norway. Int J Cancer 1993; 55: 555-561.
16. Odenbro A, Gillgren P, Bellocco R et al. The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index. Br J Dermatol 2007; 156: 99-105.
17. Shors AR, Solomon C, McTiernan A, White E. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control 2001; 12: 599-606.
18. Wauters M, Considenie RV, Van Gaal LF. Human Leptin: From an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000; 143: 293-311.
19. Thomas T, Burguera B, Melton LJ III et al. Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism 2000; 49: 1278-1284.
20. Havel PJ, Kasim-Karakas S, Dubuc GR et al. Gender differences in plasma leptin concentration. Nat Med 1996; 2: 949-950.
21. Mantzoros CS, Liolios AD, Tritos NA et al. Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men, Obes Res 1998; 6: 179-186.
22. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207: 12-22.
23. Tessitore L, Vizio B, Jenkins O et al. Leptin expression in colorectal and breast cancer patients. Int J Mol Med 2000; 5: 421-426.
24. Petridou E, Belechri M, Dessypris N et al. Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 2002; 46: 147-151.
25. Mantzoros CS, Trakatelli M, Gogas H. Circulating adiponectin levels in relation to melanoma: A case control study. Eur J Cancer 2007; 43: 1430-1436.
26. Spyridopoulos TN, Petridou ET, Skalkidou A et al. Low adiponectin levels are associated with renal cell carcinoma: A case-control study. Int J Cancer 2007; 120: 1573-1578.
27. Fitzpatrick TB. The validity and practicability of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-871.
28. Passmore R, Eastwood MA. Davidson and Passmore Human Nutrition and Dietetics, 8th edition. Edinburgh, London: Churchill Livingstone 1986.
29. Petridou E, Ntouvelis E, Dessypris N et al. Matemal diet and acute lymphoblastic leukemia in young children. Cancer Epidemiol Biomarkers Prev 2005; 14: 1935-1939.
30. Petridou E, Kedikoglou S, Koukoulomatis P et al. Diet in relation to endometrial cancer risk: A case-control study in Greece. Nutr Cancer 2002; 44: 16-22.
31. Petridou E, Mantzoros CS, Belechri M et al. Neonatal leptin levels are strongly associated with female gender, birth length, IGF-I levels and formula feeding. Clin Endocrinol (Oxf) 2005; 62: 366-371.
32. SAS Institute Inc. SAS/STAT User's Guide, Version 6. 4th edition. Cay, NC: SAS Institute 1989.
33. Lasithiotakis K, Leiter U, Kruger-Krasagakis S et al. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Wuttemberg). Br J Dermatol 2006; 154: 1123-1127.
34. Westerdahl J, Olsson H, Masback A et al. Risk of malignant melanoma in relation to drug intake, alcohol, smoking and hormonal factors. Br J Cancer 1996; 73: 1126-1131.
35. Mackie BS, Mackie LE, Curtin LD, Bourne DJ. Melanoma and dietary lipids. Nutr Cancer 1987; 9: 219-226.
36. Masuzaki H, Hosoda K, Ogawa Y et al. Augmented expression of obese (ob) gene during the process of obesity in genetically obese hyperglycemic Wistar fatty (fa/fa) rats, FEBS Lett 1996; 378: 267-271.
37. Bonnet M, Delavaud C, Laud K et al. Mammary leptin synthesis, milk leptin and their putative physiological roles. Reprod Nutr Dev 2002; 42: 399-413.
38. Brann DW, Wade MF, Dhandapani KM et al. Leptin and reproduction. Steroids 2002; 67: 95-104.
39. Leroy P, Dessolin S, Villageois P et al. Expression of ob gene in adipose cells. Regulation by insulin. J Biol Chem 1996; 271: 2365-2368.
40. Zhang HH, Kumar S, Barnett AH, Eggo MC. Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Moll Cell Endocrinol 2000; 159: 79-88,
41. Dagogo-Jack S, Selke G, Melson AK, Newcomer Jw. Robust leptin secretory responses to dexamethasone in obese subjects. J Clin Endocrinol Metab 1997; 82: 3230-3233.
42. Machinal-Quelin F, Dieudonne MN, Pecquery R. Direct in vitro effects of androgens and-estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine 2002; 18: 179-184.
43. Fain JN, Leffler Cw, Bahouth Sw. Eicosanoids as endogenous regulators of leptin release and lipolysis by mouse adipose tissue in primary culture. J Lipid Res 2000; 41: 1689-1694.
44. Stattin P, Palmqvist R, Soderberg S et al. Plasma leptin and colorectal cancer risk: A prospeclive study in Northern Sweden. Oncol Rep 2003b; 10: 2015-11021.
45. Crosfeld A, Andre J, Hauguel-De Mouzon S et al. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002; 277: 42953-42957.
46. Cao R, Brakenhielm E, Wahlestedt C et al. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 2001; 98: 6390-6395.
47. Artwohl M, Roden M, Holzenbein T et al. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obes Relat Metab Disord 2002; 26: 577-580.
48. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci 2001; 47: 141-150.
49. Hardwick JC, Van Den Brink GR, Offerhaus GJ et al. Leptin is a growth factor for colonic epithelial cells. Gastroenterology 2001; 121: 79-90.
50. Dieudonne MN, Machinal-Quelin F, Serazin-Leroy V et al. Leptin mediates a prolifeŕative response in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2002; 293: 622-628.
51. de Vries E, Boniol M, Severi G et al. Public awareness about risk factors could pose problems for case-control studies: The example of sunbed use and cutaneous melanoma. Eur J Cancer 2005; 41: 2150-2154.